These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 3889068

  • 41. [Immunohistochemical evaluation of several tumor markers (CEA, ferritin, Ca) and their correlation with estro-progestin receptor state in neoplasms].
    Forti E, Wolf D, Melia M.
    Pathologica; 1985; 77(1049):241-9. PubMed ID: 3913892
    [No Abstract] [Full Text] [Related]

  • 42. Biochemical and histological characterization of antigens preferentially expressed on the surface and cytoplasm of breast carcinoma cells identified by monoclonal antibodies against the human milk fat globule.
    Peterson JA, Zava DT, Duwe AK, Blank EW, Battifora H, Ceriani RL.
    Hybridoma; 1990 Jun; 9(3):221-35. PubMed ID: 2365381
    [Abstract] [Full Text] [Related]

  • 43. Immunohistochemical detection of the Ca antigen in normal and tumor tissues of humans by use of Ca1 monoclonal antibody.
    Woodhouse CS, Seiler C, Morgan AC, Oldham RK.
    J Natl Cancer Inst; 1985 Feb; 74(2):383-9. PubMed ID: 3883035
    [Abstract] [Full Text] [Related]

  • 44. Hybridoma antibody to breast cancer immune complexes.
    Papsidero LD, Nemoto T, Valenzuela L, Chu TM.
    Hybridoma; 1982 Feb; 1(3):275-82. PubMed ID: 6765320
    [Abstract] [Full Text] [Related]

  • 45. Production and characterization of monoclonal antibodies showing a different spectrum of reactivity to human breast tissue.
    Mandeville R, Giroux L, Lecomte J, Chausseau JP, Dumas F, Ajdukovic I, Vidal D, Boury F.
    Cancer Detect Prev; 1987 Feb; 10(1-2):89-100. PubMed ID: 2436777
    [Abstract] [Full Text] [Related]

  • 46. [Clinical evaluation of serum CA-50 measurement in breast diseases --relation to the progress of breast cancer].
    Shiga T, Kawauchi A, Kamiya K, Ishii J, Uzawa R, Gomi K.
    Rinsho Byori; 1986 Nov; 34(11):1339-45. PubMed ID: 3469447
    [No Abstract] [Full Text] [Related]

  • 47. Characterization and distribution in human tissues of a glycoproteic antigen defined by monoclonal antibody 1BE12 raised against the human breast cancer cell line T47D.
    Pancino G, Charpin C, Osinaga E, Betaille B, Le Roy M, Calvo F, Roseto A.
    Cancer Res; 1990 Nov 15; 50(22):7333-42. PubMed ID: 2224861
    [Abstract] [Full Text] [Related]

  • 48. Analysis of the tumour-associated antigen TAG-12 by monoclonal antibody 7A9 in normal, benign and malignant mammary tissues.
    Werner M, von Wasielewski R, Bernhards J, Georgii A.
    Virchows Arch A Pathol Anat Histopathol; 1990 Nov 15; 416(5):411-6. PubMed ID: 2156377
    [Abstract] [Full Text] [Related]

  • 49. Serum level of cryptic tumor antigens in breast cancer patients as determined by two monoclonal antibodies (M85/F36) and its comparison with CA 15-3.
    Chu TM, Constantine R, Nemoto T.
    J Clin Lab Anal; 1989 Nov 15; 3(5):267-72. PubMed ID: 2681619
    [Abstract] [Full Text] [Related]

  • 50. Characterisation of breast cancer infiltrates using monoclonal antibodies to human leucocyte antigens.
    Rowe DJ, Beverley PC.
    Br J Cancer; 1984 Feb 15; 49(2):149-59. PubMed ID: 6365132
    [Abstract] [Full Text] [Related]

  • 51. Presence of HLA-D/DR antigens on the membrane of breast tumour cells.
    Bernard D, Maurizis JC, Rusé F, Chassagne J, Chollet P, Sauvezie B, de Latour M, Plagne R.
    Clin Exp Immunol; 1984 Apr 15; 56(1):215-21. PubMed ID: 6370519
    [Abstract] [Full Text] [Related]

  • 52. [Indirect immunofluorescence with autoantibodies on cryostat sections of human tumors].
    Kasper M, Stosiek P, Varga A.
    Arch Geschwulstforsch; 1983 Apr 15; 53(2):99-104. PubMed ID: 6344837
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Multi-parameter flow cytometric quantitation of the expression of the tumor-associated antigen SM3 in normal and neoplastic ovarian tissues. A comparison with HMFG1 and HMFG2.
    van Dam PA, Lowe DG, Watson JV, Jobling TW, Chard T, Shepherd JH.
    Cancer; 1991 Jul 01; 68(1):169-77. PubMed ID: 2049739
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Monoclonal antibodies (F36/22 and M7/105) to human breast carcinoma.
    Papsidero LD, Croghan GA, O'Connell MJ, Valenzuela LA, Nemoto T, Chu TM.
    Cancer Res; 1983 Apr 01; 43(4):1741-7. PubMed ID: 6339043
    [Abstract] [Full Text] [Related]

  • 59. Expression of tumor-associated antigen (DF3) in atypical hyperplasias and in situ carcinomas of the human breast.
    Ohuchi N, Page DL, Merino MJ, Viglione MJ, Kufe DW, Schlom J.
    J Natl Cancer Inst; 1987 Jul 01; 79(1):109-17. PubMed ID: 3298784
    [Abstract] [Full Text] [Related]

  • 60. A spectrum of monoclonal antibodies reactive with human mammary tumor cells.
    Colcher D, Hand PH, Nuti M, Schlom J.
    Proc Natl Acad Sci U S A; 1981 May 01; 78(5):3199-203. PubMed ID: 6789331
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.